Sterling Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.3M | Buy |
|
|||||
|
2025
Q2 | $24.9M | Sell |
|
|||||
|
2025
Q1 | $31.4M | Sell |
|
|||||
|
2024
Q4 | $45.7M | Sell |
|
|||||
|
2024
Q3 | $41.6M | Buy |
|
|||||
|
2019
Q3 | $858K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $820K | Hold |
|
|||||
|
2018
Q2 | $925K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $263K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $529K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $208K | Sell |
|
|||||
|
2014
Q2 | $564K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $56M | Sell |
|
|||||
|
2013
Q3 | $62.1M | Sell |
|
|||||
|
2013
Q2 | $65.6M | Buy |
|